Cargando…

Discovery of Oxazol-2-amine Derivatives as Potent Novel FLT3 Inhibitors

Internal tandem duplication (ITD) of FMS-like tyrosine kinase 3 (FLT3) is the most common mutation in patients with acute myeloid leukemia (AML). FLT3-ITD(+) induces constitutive activation of FLT3, causing an abnormally rapid proliferation of cancer cells. In this study, we identified novel FLT3 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyo Jeong, Ryu, Hwani, Song, Jie-Young, Hwang, Sang-Gu, Jalde, Shivakumar S., Choi, Hyun-Kyung, Ahn, Jiyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663913/ https://www.ncbi.nlm.nih.gov/pubmed/33167505 http://dx.doi.org/10.3390/molecules25215154

Ejemplares similares

Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor
por: Ryu, Hwani, et al.
Publicado: (2021)

Antitumor Activity of a Novel Tyrosine Kinase Inhibitor AIU2001 Due to Abrogation of the DNA Damage Repair in Non-Small Cell Lung Cancer Cells
por: Ryu, Hwani, et al.
Publicado: (2019)

A Small Compound KJ-28d Enhances the Sensitivity of Non-Small Cell Lung Cancer to Radio- and Chemotherapy
por: Ryu, Hwani, et al.
Publicado: (2019)

An iron-chelating sulfonamide identified from Drosophila-based screening for antipathogenic discovery
por: Yoo, Yeon-Ji, et al.
Publicado: (2022)

Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2017)

Correction: Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2018)

Iodine-Catalyzed Functionalization of Primary Aliphatic Amines to Oxazoles, 1,4-Oxazines, and Oxazinones
por: Debnath, Sudipto, et al.
Publicado: (2019)

In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors
por: Hao, Ming, et al.
Publicado: (2011)

Momelotinib is a highly potent inhibitor of FLT3-mutant AML
por: Azhar, Mohammad, et al.
Publicado: (2022)

TGF-β and Hypoxia/Reoxygenation Promote Radioresistance of A549 Lung Cancer Cells through Activation of Nrf2 and EGFR
por: Lee, Sae-lo-oom, et al.
Publicado: (2016)

An antipathogenic compound that targets the OxyR peroxide sensor in Pseudomonas aeruginosa
por: Oh, Hyo-Young, et al.
Publicado: (2021)

Hypervalent iodine-promoted twofold oxidative coupling of amines with amides and thioamides: chemoselective pathway to oxazoles and thiazoles
por: Nan, Jiang, et al.
Publicado: (2023)

Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton’s Tyrosine Kinase
por: Lee, Eun, et al.
Publicado: (2020)

3,4-Dimethyl-N-[(E)-3-nitrobenzylidene]-1,2-oxazol-5-amine
por: Asiri, Abdullah M., et al.
Publicado: (2010)

5-(4-Fluorophenyl)-4-(4-pyridyl)-1,3-oxazol-2-amine
por: Koch, Pierre, et al.
Publicado: (2010)

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
por: Ma, Shuang, et al.
Publicado: (2015)

UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
por: Zhang, Weihe, et al.
Publicado: (2014)

Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis
por: Zheng, Xunan, et al.
Publicado: (2020)

Discovery of Sulforaphane as a Potent BACE1 Inhibitor Based on Kinetics and Computational Studies
por: Youn, Kumju, et al.
Publicado: (2020)

Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
por: Choi, Sujin, et al.
Publicado: (2020)

N-[(E)-Anthracen-9-ylmethylidene]-3,4-dimethyl-1,2-oxazol-5-amine
por: Asiri, Abdullah M., et al.
Publicado: (2011)

New Prospective Phosphodiesterase Inhibitors: Phosphorylated Oxazole Derivatives in Treatment of Hypertension
por: Nizhenkovska, Iryna V., et al.
Publicado: (2023)

Dual FLT3/TOPK inhibitor with activity against FLT3-ITD secondary mutations potently inhibits acute myeloid leukemia cell lines
por: Dayal, Neetu, et al.
Publicado: (2018)

Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia
por: Jarusiewicz, Jamie A., et al.
Publicado: (2017)

Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
por: Zhang, Yvyin, et al.
Publicado: (2023)

Amphiphilic Aminated Derivatives of [60]Fullerene as Potent Inhibitors of Tumor Growth and Metastasis
por: Huo, Jiawei, et al.
Publicado: (2022)

Thiazole and Oxazole Alkaloids: Isolation and Synthesis
por: Davyt, Danilo, et al.
Publicado: (2010)

Naturally Occurring Oxazole-Containing Peptides
por: Mhlongo, Jessica T., et al.
Publicado: (2020)

N-[(E)-1,3-Benzodioxol-5-ylmethylidene]-3,4-dimethyl-1,2-oxazol-5-amine
por: Asiri, Abdullah M., et al.
Publicado: (2011)

Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease
por: Al-Wahaibi, Lamya H., et al.
Publicado: (2021)

Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite
por: Li, Jianke, et al.
Publicado: (2019)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD(+) AML cell growth
por: Weir, Mark C., et al.
Publicado: (2017)

Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton’s Tyrosine Kinase Inhibitor
por: Lee, Keun Woo, et al.
Publicado: (2020)

QSAR Accelerated Discovery of Potent Ice Recrystallization Inhibitors
por: Briard, Jennie G., et al.
Publicado: (2016)

Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors
por: Cuffaro, Doretta, et al.
Publicado: (2021)

Discovery and characterization of potent And‐1 inhibitors for cancer treatment
por: Li, Jing, et al.
Publicado: (2021)

Discovery of 2-aminoquinolone acid derivatives as potent inhibitors of SARS-CoV-2
por: Shin, Young Sup, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents
por: Romagnoli, Romeo, et al.
Publicado: (2017)

Natural-Product-Directed Catalytic Stereoselective Synthesis of Functionalized Fused Borane Cluster–Oxazoles for the Discovery of Bactericidal Agents
por: Varkhedkar, Rajesh, et al.
Publicado: (2022)

Continuous multistep synthesis of 2-(azidomethyl)oxazoles
por: Rossa, Thaís A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ecvkubgj4j8msvm2ntu0ueh5ci